Eldaif Shady M, Mutrie Christopher J, Rutledge W Caleb, Lin Edward, Force Seth D, Miller Joseph I, Mansour Kamal A, Miller Daniel L
Division of General Thoracic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Ann Thorac Surg. 2009 May;87(5):1558-62; discussion 1562-3. doi: 10.1016/j.athoracsur.2009.02.078.
Esophagomyotomy is the mainstay of treatment for achalasia with proven long-term success. However, in patients with a significantly dilated esophagus, many advocate esophageal resection thus forgoing an esophagomyotomy. The purpose of this study is to determine the esophagomyotomy failure rate in patients with achalasia.
A retrospective review of all patients with achalasia who underwent an esophagomyotomy from 1996 to 2006; 272 patients were divided into three groups based on their preoperative degree of esophageal dilation for comparison. The endpoint for esophagomyotomy failure was persistent symptoms requiring any intervention.
The preoperative characteristics were comparable except for the severely dilated esophagus patients who had a longer duration of preoperative symptoms. Group I (mild dilatation) had 162 patients with 7 failures requiring intervention. Group II (moderate dilatation) had 74 patients with 4 failures and group III (severe dilatation) had 36 patients with 5 patients requiring intervention. For the entire cohort, median follow-up was 37 months (range, 8 to 144 months). There was no statistically significant difference among the groups in the number of patients requiring reintervention. The overall esophagectomy rate was only 2%. However, there was a significantly higher (p = 0.02) esophagectomy rate in the severely dilated patients.
The degree of esophageal dilatation associated with achalasia does not influence the success of an esophagomyotomy. Of the entire patient population in this study, only 6 patients required an esophagectomy. The majority of patients with the most severely dilated esophagus did not require an esophagectomy. Esophagomyotomy should be the first treatment option for patients with achalasia no matter what the degree of esophageal dilatation.
食管肌层切开术是治疗贲门失弛缓症的主要方法,长期疗效已得到证实。然而,对于食管明显扩张的患者,许多人主张行食管切除术,从而放弃食管肌层切开术。本研究的目的是确定贲门失弛缓症患者食管肌层切开术的失败率。
回顾性分析1996年至2006年所有接受食管肌层切开术的贲门失弛缓症患者;根据术前食管扩张程度将272例患者分为三组进行比较。食管肌层切开术失败的终点是持续存在需要任何干预的症状。
除食管严重扩张的患者术前症状持续时间较长外,术前特征具有可比性。第一组(轻度扩张)有162例患者,7例失败需要干预。第二组(中度扩张)有74例患者,4例失败,第三组(重度扩张)有36例患者,5例需要干预。对于整个队列,中位随访时间为37个月(范围8至144个月)。各组间需要再次干预的患者数量无统计学显著差异。总体食管切除术率仅为2%。然而,严重扩张患者的食管切除术率显著更高(p = 0.02)。
与贲门失弛缓症相关的食管扩张程度不影响食管肌层切开术的成功率。在本研究的整个患者群体中,只有6例患者需要行食管切除术。大多数食管扩张最严重的患者不需要行食管切除术。无论食管扩张程度如何,食管肌层切开术都应是贲门失弛缓症患者的首选治疗方法。